瓦伦西亚良性前列腺增生症管理的变化:现实世界的证据分析
J Navarro-Pérez1, E López Alcina2, J Calabiug Pérez3
1Hospital Clínico Universitario de Valencia, INCLIVA, Universidad de Valencia, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Valencia, Spain.
Actas urologicas espanolas
|February 18, 2024
概括
一个培训计划改善了全科医生对良性前列腺增生症 (BPH) 的管理,增加了诊断指标和组合治疗处方. 然而,对手术结果的影响需要更长的观察.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 一般实践一般实践
- 改善医疗保健质量 改善医疗保健质量
背景情况:
- 良性前列腺增生症 (BPH) 管理需要全科医生的最佳参与.
- 开发了一项培训计划,以加强BPH护理的提供.
研究的目的:
- 评估培训计划对全科医生的BPH管理的影响.
- 评估BPH质量指标和培训后治疗结果的变化.
主要方法:
- 观察性回顾性队列研究分析了2010年,2012年和2015年的汇总数据.
- 对118,795名患者的BPH诊断,治疗和结果的质量指标的评估.
主要成果:
- 国际前列腺症状评分 (IPSS) 和前列腺特异性抗原 (PSA) 确定值的显著增加.
- 增加了组合疗法 (α阻断剂+5-ARI) 的处方,但摄入量仍然很低.
- 新诊断BPH患者的泌尿器科转诊减少;手术率初步增加,然后稳定.
结论:
- 该培训计划对初级保健中的BPH患者管理产生了积极的影响.
- 需要进一步观察以确定培训对BPH手术干预率的长期影响.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
619
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
619
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
613
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
613
Mitral Stenosis III: Medical Management
538
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
538
Urinary Tract Calculi III: Medical Management
402
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
402
Urinary Tract Calculi VI: Surgical Management
1.0K
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
1.0K


